Acute Management of Subarachnoid Hemorrhage
Patients with suspected or confirmed subarachnoid hemorrhage require immediate emergency treatment including rapid diagnostic confirmation, urgent transfer to a specialized neurocritical care center, early aneurysm securing (ideally within 24 hours), blood pressure control with titratable agents, and oral nimodipine 60 mg every 4 hours for 21 consecutive days. 1, 2
Immediate Diagnostic Workup
For patients presenting with acute severe headache, obtain a noncontrast head CT immediately to confirm or exclude SAH. 1
If the patient presents <6 hours from symptom onset without neurological deficit, a high-quality CT interpreted by a board-certified neuroradiologist may be sufficient to exclude SAH (sensitivity 95-100% within 12 hours). 1
If the patient presents >6 hours from symptom onset or has any neurological deficit, perform lumbar puncture for xanthochromia analysis if the CT is negative, as CT sensitivity declines to 93% at 24 hours and 57-85% by day 6. 1, 3
Spectrophotometric analysis for xanthochromia has 100% sensitivity and 95.2% specificity when performed >6 hours after symptom onset. 1
Once SAH is confirmed, perform digital subtraction angiography (DSA) to identify the aneurysm source and determine optimal treatment strategy. 1
Emergency Stabilization and Transfer
Immediately transfer the patient to a high-volume center (>35 SAH cases/year) with neurosurgical, neuroendovascular, and neurocritical care expertise. 2, 3
Ensure airway protection—if intubation is required, use rapid sequence protocols with attention to preoxygenation and avoiding blood pressure fluctuations. 1
Document Hunt and Hess grade or World Federation of Neurological Surgeons scale immediately, as initial clinical grade is the strongest predictor of outcome. 1, 4
Admit to a dedicated neurocritical care unit with multidisciplinary protocols and frequent neurological assessments. 2, 5
Blood Pressure Management
Control blood pressure with short-acting, titratable intravenous agents (such as nicardipine or labetalol) to maintain systolic BP <160 mm Hg while avoiding hypotension (maintain MAP ≥65 mm Hg). 1, 2, 4
In severely hypertensive patients (systolic >180-200 mm Hg), reduce BP gradually to balance rebleeding risk against cerebral perfusion. 2
Hypotension is absolutely contraindicated as it compromises cerebral perfusion and worsens outcomes. 2
Continue strict BP control until the aneurysm is secured. 2, 4
Nimodipine Administration
Start oral nimodipine 60 mg (two 30 mg capsules) every 4 hours immediately and continue for 21 consecutive days to prevent delayed cerebral ischemia. 2, 6
Therapy should commence within 96 hours of SAH onset. 6
If the patient cannot swallow, extract capsule contents with an 18-gauge needle and administer via nasogastric tube followed by 30 mL normal saline flush, or use rectal suppository (325 mg daily). 1, 2, 6
Never administer nimodipine intravenously—this can cause life-threatening hypotension. 6
Aneurysm Securing
Secure the ruptured aneurysm as early as feasible, ideally within 24 hours, to prevent rebleeding (which carries 70-80% mortality). 1, 2
For anterior circulation aneurysms amenable to both techniques, endovascular coiling is preferred over surgical clipping to achieve better 1-year functional outcomes. 1, 2
For posterior circulation aneurysms, strongly favor endovascular coiling (relative risk 0.41 for death or dependency versus clipping). 2
For patients with large intraparenchymal hematoma and depressed consciousness, perform emergency surgical clot evacuation combined with aneurysm clipping—this reduces mortality from approximately 80% to 27%. 2
For wide-neck aneurysms not amenable to primary coiling or clipping, stent-assisted coiling or flow-diverter devices are reasonable options. 2
Avoid stents or flow diverters for ruptured saccular aneurysms that can be treated with primary coiling or clipping, as they increase complication rates. 2
Evaluation by both neurosurgical and endovascular specialists is necessary to determine optimal treatment approach. 5
Management of Acute Hydrocephalus
If acute symptomatic hydrocephalus develops, perform urgent cerebrospinal fluid diversion via external ventricular drain (EVD) or lumbar drain. 2, 5
Use standardized EVD bundle protocols addressing all aspects of management. 1
This is particularly critical in patients with intraventricular hemorrhage. 5
Fluid Management
Maintain euvolemia with goal-directed volume management—do NOT use prophylactic hypervolemia ("triple-H therapy"). 2, 4
Prophylactic hypervolemia does not prevent delayed cerebral ischemia and may cause harm. 2, 4
Monitor volume status closely and treat deviations promptly. 5
Antiplatelet and Anticoagulant Management
Withhold aspirin and other antiplatelet agents until after the aneurysm is secured. 2
If the patient is anticoagulated, perform emergency reversal of anticoagulation. 2
After aneurysm securing, initiate venous thromboembolism prophylaxis. 2
Critical Pitfalls to Avoid
Do not delay aneurysm treatment beyond 24 hours when feasible—early rebleeding carries 70-80% mortality and risk increases progressively. 1, 2
Do not use prophylactic hypervolemia, which lacks supporting evidence and may be detrimental. 2, 4
Do not allow hypotension (MAP <65 mm Hg), as it compromises cerebral perfusion. 2
Do not use stents or flow diverters for ruptured saccular aneurysms amenable to primary coiling or clipping. 2
Do not administer nimodipine intravenously—this is potentially fatal. 6
Do not miss the diagnosis—SAH is misdiagnosed in up to 12% of cases, and failure to identify a sentinel bleed before catastrophic rupture can be fatal. 1, 3
Monitoring for Complications
Implement frequent neurological assessments with validated dysphagia screening protocols. 5
Monitor specifically for rebleeding, hydrocephalus, delayed cerebral ischemia, seizures, and systemic complications. 4
Avoid systemic insults including hyperglycemia, acidosis, electrolyte abnormalities, hypoxia, and hyperthermia—all worsen outcomes. 4
If delayed cerebral ischemia develops after aneurysm securing, induce hypertension while maintaining euvolemia (unless baseline BP is already elevated or cardiac status precludes it). 2, 5